The role of ADRB2 gene polymorphisms in malignancies

被引：15
|
作者：
Wang, Yaqian [1 ]
Jiang, Shujuan [1 ,2 ,3 ]
机构：
[1] Shandong Univ, Shandong Prov Hosp, Cheeloo Coll Med, Dept Resp & Crit Care Med, Jingwu Rd 324, Jinan 250021, Shandong, Peoples R China
[2] Shandong First Med Univ, Shandong Prov Hosp, Dept Resp & Crit Care Med, Jinan 250021, Shandong, Peoples R China
[3] Shandong Key Lab Infect Resp Dis, Jinan 250021, Shandong, Peoples R China
来源：
MOLECULAR BIOLOGY REPORTS | 2021年 / 48卷 / 03期
关键词：
ADRB2; Malignancy; Single nucleotide polymorphism; β (2)-Adrenergic receptor; BETA-2-ADRENERGIC RECEPTOR GENE; CELL LUNG-CANCER; SINGLE NUCLEOTIDE POLYMORPHISMS; 5' LEADER CISTRON; BETA-BLOCKERS; BREAST-CANCER; PROMOTER POLYMORPHISMS; ANTAGONIST PROPRANOLOL; SMOOTH-MUSCLE; KAPPA-B;
D O I：
10.1007/s11033-021-06250-y
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Beta-2-adrenergic receptor is a member of the G protein-coupled receptor superfamily, which is highly expressed in most malignancies. There is increasing evidence showing that beta-2-adrenergic receptors are associated with carcinogenesis, proliferation, immune regulation, invasion, angiogenesis, clinical prognosis and treatment resistance in malignancies. Polymorphisms of the ADRB2 gene have been confirmed to be associated with transcriptional activity, mRNA translation, and beta-2-adrenergic receptor expression and sensitivity. This review discusses clinically relevant examples of single nucleotide polymorphisms of ADRB2 in malignancies and the effects of these polymorphisms on cancer susceptibility, prognosis and treatment response of cancer patients.
引用
收藏
页码：2741 / 2749
页数：9
相关论文
共 50 条
  • [21] ADRB2 Polymorphisms and Dyslipidemia Risk in Chinese Hypertensive Patients
    Wei, Gu
    Wen, Shaojun
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (16) : C2 - C3
  • [22] The pharmacogenetic effect of ADRB2 polymorphisms on therapeutic response in COPD
    Mustafina, Malika
    Tsvetkova, Olga
    Generozov, Eduard
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [23] ADRB2 polymorphisms and dyslipidemia risk in Chinese hypertensive patients
    Gu, Wei
    Liu, Jilin
    Wang, Zuoguang
    Liu, Ya
    Wen, Shaojun
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2017, 39 (02) : 139 - 144
  • [24] Further evidence for a role of the ADRB2 gene in risk for posttraumatic stress disorder
    Hauser, Michael A.
    Garrett, Melanie E.
    Liu, Yutao
    Dennis, Michelle F.
    Kimbrel, Nathan A.
    Beckham, Jean C.
    Ashley-Koch, Allison E.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2017, 84 : 59 - 61
  • [25] The median number of COPD exacerbations per year in patients with different polymorphisms of the gene ADRB2
    Mustafina, Malika
    Tsvetkova, Olga
    Generozov, Eduard
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [26] β2-Adrenergic Receptor (ADRB2) Gene Polymorphisms and Risk of COPD Exacerbations: The Rotterdam Study
    Karimi, Leila
    Lahousse, Lies
    Ghanbari, Mohsen
    Terzikhan, Natalie
    Uitterlinden, Andre G.
    van der Lei, Johan
    Brusselle, Guy G.
    Stricker, Bruno H.
    Verhamme, Katia M. C.
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (11)
  • [27] Age-dependent influence of ADRB2 gene polymorphisms on asthma severity in Serbian population
    Petrovic-Stanojevic, Natasa
    Topic, Aleksandra
    Nikolic, Aleksandra
    Stankovic, Marija
    Dopudja-Pantic, Vesna
    Milenkovic, Branislava
    Radojkovic, Dragica
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [28] Polymorphisms of the β2-adrenergic receptor gene (ADRB2) in relation to cardiovascular risk factors in men
    Rosmond, R
    Ukkola, O
    Chagnon, M
    Bouchard, C
    Björntorp, P
    JOURNAL OF INTERNAL MEDICINE, 2000, 248 (03) : 239 - 244
  • [29] Evolutionary History of the ADRB2 Gene in Humans Response
    Fumagalli, Matteo
    Cagliani, Rachele
    Pozzoli, Uberto
    Sironi, Manuela
    AMERICAN JOURNAL OF HUMAN GENETICS, 2010, 86 (03) : 493 - 495
  • [30] The Role of ADRB2 in Myasthenia: Genetic and Immunological Factors
    V. B. Lantsova
    A. S. Gerasimov
    E. K. Sepp
    Bulletin of Experimental Biology and Medicine, 2013, 154 : 351 - 353
12345